Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 May 1;25(9):1678–1684. doi: 10.1093/nar/25.9.1678

Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression.

K Savitsky 1, M Platzer 1, T Uziel 1, S Gilad 1, A Sartiel 1, A Rosenthal 1, O Elroy-Stein 1, Y Shiloh 1, G Rotman 1
PMCID: PMC146671  PMID: 9108147

Abstract

Mutations in the ATM gene are responsible for the multisystem disorder ataxia-telangiectasia, characterized by neurodegeneration, immune deficiency and cancer predisposition. While no alternative splicing was identified within the coding region, the first four exons of the ATM gene, which fall within the 5'untranslated region (UTR), undergo extensive alternative splicing. We identified 12 different 5'UTRs that show considerable diversity in length and sequence contents. These mRNA leaders, which range from 150 to 884 nucleotides (nt), are expected to form variable secondary structures and contain different numbers of AUG codons. The longest 5'UTR contains a total of 18 AUGs upstream of the translation start site. The 3'UTR of 3590 nt is contained within a single 3'exon. Alternative polyadenylation results in 3'UTRs of varying lengths. These structural features suggest that ATM expression might be subject to complex post-transcriptional regulation, enabling rapid modulation of ATM protein level in response to environmental stimuli or alterations in cellular physiological states.

Full Text

The Full Text of this article is available as a PDF (140.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoubi T. A., Van De Ven W. J. Regulation of gene expression by alternative promoters. FASEB J. 1996 Mar;10(4):453–460. [PubMed] [Google Scholar]
  2. Bernstein J., Sella O., Le S. Y., Elroy-Stein O. PDGF2/c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES). J Biol Chem. 1997 Apr 4;272(14):9356–9362. doi: 10.1074/jbc.272.14.9356. [DOI] [PubMed] [Google Scholar]
  3. Byrd P. J., Cooper P. R., Stankovic T., Kullar H. S., Watts G. D., Robinson P. J., Taylor M. R. A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies. Hum Mol Genet. 1996 Nov;5(11):1785–1791. doi: 10.1093/hmg/5.11.1785. [DOI] [PubMed] [Google Scholar]
  4. Byrd P. J., McConville C. M., Cooper P., Parkhill J., Stankovic T., McGuire G. M., Thick J. A., Taylor A. M. Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. Hum Mol Genet. 1996 Jan;5(1):145–149. doi: 10.1093/hmg/5.1.145. [DOI] [PubMed] [Google Scholar]
  5. Chen C. Y., Shyu A. B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 1995 Nov;20(11):465–470. doi: 10.1016/s0968-0004(00)89102-1. [DOI] [PubMed] [Google Scholar]
  6. Code R. J., Olmsted J. B. Mouse microtubule-associated protein 4 (MAP4) transcript diversity generated by alternative polyadenylation. Gene. 1992 Dec 15;122(2):367–370. doi: 10.1016/0378-1119(92)90228-h. [DOI] [PubMed] [Google Scholar]
  7. Decker C. J., Parker R. Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol. 1995 Jun;7(3):386–392. doi: 10.1016/0955-0674(95)80094-8. [DOI] [PubMed] [Google Scholar]
  8. Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., Rotman G., Smith S., Chessa L., Jorgensen T. J. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 1996 Apr;5(4):433–439. doi: 10.1093/hmg/5.4.433. [DOI] [PubMed] [Google Scholar]
  9. Harnden D. G. The nature of ataxia-telangiectasia: problems and perspectives. Int J Radiat Biol. 1994 Dec;66(6 Suppl):S13–S19. [PubMed] [Google Scholar]
  10. Hentze M. W. Translational regulation: versatile mechanisms for metabolic and developmental control. Curr Opin Cell Biol. 1995 Jun;7(3):393–398. doi: 10.1016/0955-0674(95)80095-6. [DOI] [PubMed] [Google Scholar]
  11. Imai T., Yamauchi M., Seki N., Sugawara T., Saito T., Matsuda Y., Ito H., Nagase T., Nomura N., Hori T. Identification and characterization of a new gene physically linked to the ATM gene. Genome Res. 1996 May;6(5):439–447. doi: 10.1101/gr.6.5.439. [DOI] [PubMed] [Google Scholar]
  12. Jackson R. J. Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region. Cell. 1993 Jul 16;74(1):9–14. doi: 10.1016/0092-8674(93)90290-7. [DOI] [PubMed] [Google Scholar]
  13. Jackson S. P. Cancer predisposition. Ataxia-telangiectasia at the crossroads. Curr Biol. 1995 Nov 1;5(11):1210–1212. doi: 10.1016/s0960-9822(95)00238-7. [DOI] [PubMed] [Google Scholar]
  14. Keith C. T., Schreiber S. L. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science. 1995 Oct 6;270(5233):50–51. doi: 10.1126/science.270.5233.50. [DOI] [PubMed] [Google Scholar]
  15. Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987 Oct 26;15(20):8125–8148. doi: 10.1093/nar/15.20.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol. 1991 Nov;115(4):887–903. doi: 10.1083/jcb.115.4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci U S A. 1986 May;83(9):2850–2854. doi: 10.1073/pnas.83.9.2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kozak M. Regulation of translation in eukaryotic systems. Annu Rev Cell Biol. 1992;8:197–225. doi: 10.1146/annurev.cb.08.110192.001213. [DOI] [PubMed] [Google Scholar]
  19. Kozak M. The scanning model for translation: an update. J Cell Biol. 1989 Feb;108(2):229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lavin M. F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997;15:177–202. doi: 10.1146/annurev.immunol.15.1.177. [DOI] [PubMed] [Google Scholar]
  21. LeRoith D., Roberts C. T., Jr Insulin-like growth factors. Ann N Y Acad Sci. 1993 Aug 27;692:1–9. doi: 10.1111/j.1749-6632.1993.tb26200.x. [DOI] [PubMed] [Google Scholar]
  22. Lin B., Rommens J. M., Graham R. K., Kalchman M., MacDonald H., Nasir J., Delaney A., Goldberg Y. P., Hayden M. R. Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Hum Mol Genet. 1993 Oct;2(10):1541–1545. doi: 10.1093/hmg/2.10.1541. [DOI] [PubMed] [Google Scholar]
  23. Lu Y., Riegel A. T. The human DNA-binding protein, PO-GA, is homologous to the large subunit of mouse replication factor C: regulation by alternate 3' processing of mRNA. Gene. 1994 Aug 5;145(2):261–265. doi: 10.1016/0378-1119(94)90017-5. [DOI] [PubMed] [Google Scholar]
  24. Morris D. R. Growth control of translation in mammalian cells. Prog Nucleic Acid Res Mol Biol. 1995;51:339–363. doi: 10.1016/s0079-6603(08)60883-1. [DOI] [PubMed] [Google Scholar]
  25. Parolari A., Antona C., Rona P., Gerometta P., Huang F., Alamanni F., Arena V., Biglioli P. The effect of multiple blood conservation techniques on donor blood exposure in adult coronary and valve surgery performed with a membrane oxygenator: a multivariate analysis on 1310 patients. J Card Surg. 1995 May;10(3):227–235. doi: 10.1111/j.1540-8191.1995.tb00603.x. [DOI] [PubMed] [Google Scholar]
  26. Pesole G., Fiormarino G., Saccone C. Sequence analysis and compositional properties of untranslated regions of human mRNAs. Gene. 1994 Mar 25;140(2):219–225. doi: 10.1016/0378-1119(94)90547-9. [DOI] [PubMed] [Google Scholar]
  27. Qian J. F., Lazar-Wesley E., Breugnot C., May E. Human transforming growth factor alpha: sequence analysis of the 4.5-kb and 1.6-kb mRNA species. Gene. 1993 Oct 15;132(2):291–296. doi: 10.1016/0378-1119(93)90210-t. [DOI] [PubMed] [Google Scholar]
  28. Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 1996 May;12(5):171–175. doi: 10.1016/0168-9525(96)10016-0. [DOI] [PubMed] [Google Scholar]
  29. Sachs A. B. Messenger RNA degradation in eukaryotes. Cell. 1993 Aug 13;74(3):413–421. doi: 10.1016/0092-8674(93)80043-e. [DOI] [PubMed] [Google Scholar]
  30. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995 Jun 23;268(5218):1749–1753. doi: 10.1126/science.7792600. [DOI] [PubMed] [Google Scholar]
  31. Savitsky K., Sfez S., Tagle D. A., Ziv Y., Sartiel A., Collins F. S., Shiloh Y., Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet. 1995 Nov;4(11):2025–2032. doi: 10.1093/hmg/4.11.2025. [DOI] [PubMed] [Google Scholar]
  32. Sheets M. D., Ogg S. C., Wickens M. P. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 1990 Oct 11;18(19):5799–5805. doi: 10.1093/nar/18.19.5799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., Boehm T., Rosenthal A., Shiloh Y., Rotman G. Genomic Organization of the ATM gene. Genomics. 1996 Apr 15;33(2):317–320. doi: 10.1006/geno.1996.0201. [DOI] [PubMed] [Google Scholar]
  34. Wickens M. How the messenger got its tail: addition of poly(A) in the nucleus. Trends Biochem Sci. 1990 Jul;15(7):277–281. doi: 10.1016/0968-0004(90)90054-f. [DOI] [PubMed] [Google Scholar]
  35. Zakian V. A. ATM-related genes: what do they tell us about functions of the human gene? Cell. 1995 Sep 8;82(5):685–687. doi: 10.1016/0092-8674(95)90463-8. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES